Want to see BIVI full AI Analyst Report?
Total Valuation
BioVie has a market cap or net worth of $18.51M. The enterprise value is $1.75.
Market Cap$18.51M
Enterprise Value$1.75
Share Statistics
BioVie has 8,451,148 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,451,148
Owned by Insiders12.39%
Owned by Institutions4.33%
Financial Efficiency
BioVie’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is >-0.01%.
Return on Equity (ROE)>-0.01
Return on Assets (ROA)>-0.01
Return on Invested Capital (ROIC)>-0.01%
Return on Capital Employed (ROCE)>-0.01
Revenue Per Employee0.00
Profits Per Employee-1.70B
Employee Count13
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioVie is ―. BioVie’s PEG ratio is 0.00850.
PE Ratio―
PS Ratio0.00
PB Ratio<0.01
Price to Fair Value<0.01
Price to FCF>-0.01
Price to Operating Cash Flow-0.86
PEG Ratio0.00850
Income Statement
In the last 12 months, BioVie had revenue of 0.00 and earned -22.07M in profits. Earnings per share was -3.05.
Revenue0.00
Gross Profit0.00
Operating Income-22.65M
Pretax Income-22.07M
Net Income-22.07M
EBITDA-21.88M
Earnings Per Share (EPS)-3.05
Cash Flow
In the last 12 months, operating cash flow was -19.02M and capital expenditures -4.00, giving a free cash flow of -19.02M billion.
Operating Cash Flow-19.02M
Free Cash Flow-19.02M
Free Cash Flow per Share-2.25
Dividends & Yields
BioVie pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.00
52-Week Price Change42.11%
50-Day Moving Average1.71
200-Day Moving Average1.48
Relative Strength Index (RSI)60.75
Average Volume (3m)240.84K
Important Dates
BioVie upcoming earnings date is May 13, 2024, After Close (Confirmed).
Last Earnings DateFeb 14, 2024
Next Earnings DateMay 13, 2024
Ex-Dividend Date―
Financial Position
BioVie as a current ratio of 3.59, with Debt / Equity ratio of 2.68%
Current Ratio3.59
Quick Ratio3.59
Debt to Market Cap19.59K
Net Debt to EBITDA397.77K
Interest Coverage Ratio-1.27K
Taxes
In the past 12 months, BioVie has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioVie EV to EBITDA ratio is 397.77K, with an EV/FCF ratio of 457.40.
EV to Sales0.00
EV to EBITDA397.77K
EV to Free Cash Flow457.40
EV to Operating Cash Flow457.40
Balance Sheet
BioVie has $8.98M in cash and marketable securities with $275.43K in debt, giving a net cash position of $8.70M billion.
Cash & Marketable Securities$8.98M
Total Debt$275.43K
Net Cash$8.70M
Net Cash Per Share$1.03
Tangible Book Value Per Share$1.37M
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioVie is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target―
Price Target Upside―
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast78.51%